CAROCELL BIO LIMITED

Active London

Research and experimental development on biotechnology

2 employees website.com
Research and experimental development on biotechnologyVeterinary activities +1
C

CAROCELL BIO LIMITED

Research and experimental development on biotechnology

Founded 8 Nov 2016 Active London, England 2 employees website.com
Research and experimental development on biotechnologyVeterinary activitiesOther human health activities

Previous Company Names

BRIDGE BIOTEC LIMITED 20 Feb 2017 — 14 Aug 2019
BRIDGE BIOTEC THERAPEUTICS LIMITED 15 Nov 2016 — 20 Feb 2017
BRIDGE BIOTECH THERAPEUTICS LIMITED 8 Nov 2016 — 15 Nov 2016
Accounts Submitted 27 Aug 2025 Next due 31 Aug 2026 4 months remaining
Confirmation Submitted 13 Nov 2025 Next due 21 Nov 2026 6 months remaining
Net assets £-367K £27K 2024 year on year
Total assets £28K £996 2024 year on year
Total Liabilities £395K £26K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

London Bioscience Innovation Centre (Lbic) 2 Royal College Street London NW1 0NH England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CAROCELL BIO LIMITED (10469714), an active company based in London, England. Incorporated 8 Nov 2016. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2017–2024)

Cash in Bank

£854.00

Decreased by £6.08k (-88%)

Net Assets

-£367.20k

Decreased by £26.97k (-8%)

Total Liabilities

£394.91k

Increased by £25.98k (+7%)

Turnover

N/A

Employees

2

Decreased by 2 (-50%)

Debt Ratio

1426%

Increased by 140 (+11%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2
Grants 2

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 1Dec 2022Unknown/Other

Share Capital

Share Capital

Share allotments and capital structure

18 Allotments 1,167,114 Shares £560k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
24 Feb 20254,138£3.88£3.88
23 Dec 20244,770£19k£3.88
6 Dec 20245,153£20k£3.88
11 Nov 20242,578£10k£3.88
24 Jun 20242,690£10k£3.88

Officers

Officers

2 active
Status
Deepbridge Ned LimitedCorporate-directorUnited KingdomUnknown13 Sept 2024Active
Michael John DaviesDirectorBritishEngland648 Nov 2016Active

Shareholders

Shareholders (14)

Michael John Davies
68.1%
850,000
Kcp Nominees Ltd
15.4%
192,102

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Michael John Davies

British

Active
Notified 8 Nov 2016
Residence United Kingdom
DOB March 1962
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,ownership Of Shares 50 To 75 Percent As Firm,voting Rights 50 To 75 Percent,voting Rights 50 To 75 Percent As Firm,right To Appoint And Remove Directors,right To Appoint And Remove Directors As Trust,right To Appoint And Remove Directors As Firm,significant Influence Or Control As Trust,significant Influence Or Control As Firm

Michael John Davies

Ceased 4 Jul 2018

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
13 Nov 2025Confirmation StatementConfirmation statement made on 2025-11-07 with updates
27 Aug 2025AccountsAnnual accounts made up to 2024-11-30
18 Aug 2025Persons With Significant ControlChange to Dr Michael John Davies as a person with significant control on 2025-08-15
10 Apr 2025ResolutionResolutions
4 Apr 2025CapitalAllotment of shares (GBP 1,247.702) on 2025-02-24
13 Nov 2025 Confirmation Statement

Confirmation statement made on 2025-11-07 with updates

27 Aug 2025 Accounts

Annual accounts made up to 2024-11-30

18 Aug 2025 Persons With Significant Control

Change to Dr Michael John Davies as a person with significant control on 2025-08-15

10 Apr 2025 Resolution

Resolutions

4 Apr 2025 Capital

Allotment of shares (GBP 1,247.702) on 2025-02-24

Recent Activity

Latest Activity

Confirmation statement made on 2025-11-07 with updates

5 months ago on 13 Nov 2025

Annual accounts made up to 2024-11-30

8 months ago on 27 Aug 2025

Change to Dr Michael John Davies as a person with significant control on 2025-08-15

8 months ago on 18 Aug 2025

Resolutions

1 years ago on 10 Apr 2025

Allotment of shares (GBP 1,247.702) on 2025-02-24

1 years ago on 4 Apr 2025